AQST - Aquestive Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AQST is currently covered by 5 analysts with an average price target of $8.79. This is a potential upside of $4.48 (103.94%) from yesterday's end of day stock price of $4.31.

Aquestive Therapeutics's activity chart (see below) currently has 41 price targets and 69 ratings on display. The stock rating distribution of AQST is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.04% with an average time for these price targets to be met of 81.63 days.

Highest price target for AQST is $10, Lowest price target is $7, average price target is $8.79.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 11-Nov-2024. First documented stock forecast 20-Aug-2018.

Currently out of the existing stock ratings of AQST, 32 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$4.91 (96.46%)

$10

23 days ago
(11-Nov-2024)

8/25 (32%)

$4.93 (97.24%)

290

Buy

$9

$3.91 (76.82%)

$9

1 months 26 days ago
(08-Oct-2024)

0/10 (0%)

$4.08 (82.93%)

Buy

$7

$1.91 (37.52%)

$10

8 months 6 days ago
(28-Mar-2024)

0/8 (0%)

$2.74 (64.32%)

Buy

$8

$2.91 (57.17%)

8 months 27 days ago
(07-Mar-2024)

1/5 (20%)

$2.32 (40.85%)

52

Buy

$9

$3.91 (76.82%)

$4

8 months 27 days ago
(07-Mar-2024)

5/6 (83.33%)

$3.32 (58.45%)

259

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AQST (Aquestive Therapeutics) average time for price targets to be met?

On average it took 81.63 days on average for the stock forecasts to be realized with a an average price target met ratio 20.04

Which analyst has the current highest performing score on AQST (Aquestive Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on AQST (Aquestive Therapeutics) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?

Raghuram Selvaraju has 3 price targets and 18 ratings on AQST

Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?

Francois Brisebois with highest potential upside - $6.3

Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?

Gary Nachman with lowest potential downside - $1.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?